Subtherapeutic concentrations of posaconazole tablet: determining risk factors and effectiveness of a standardized dose adjustment in hematology inpatients-Reference-Cited by-同舟云学术

Subtherapeutic concentrations of posaconazole tablet: determining risk factors and effectiveness of a standardized dose adjustment in hematology inpatients

Published:2022-09-29 Issue:14 Volume:63 Page:3418-3425
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Bui Jessica¹²^ORCID,Gellatly Rochelle³⁴^ORCID,Othman Jad⁵^ORCID,Lindsay Julian⁵⁶⁷^ORCID

Affiliation:

1. Clinical Pharmacy Department, Royal North Shore Hospital, Sydney, Australia

2. Department of Infectious Diseases, Royal North Shore Hospital, Sydney, Australia

3. Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia

4. Pharmacy Department, Surrey Memorial Hospital, Surrey, Canada

5. Haematology Department, Royal North Shore Hospital, Sydney, Australia

6. National Centre for Infection in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia

7. Vaccine and Infectious Disease and Clinical Research Division, Fred Hutchinson Cancer Research Center, SE, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2126282

Reference46 articles.

1. Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021

2. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update

3. Pbs.gov.au. 2018. Pharmaceutical Benefits Scheme (PBS) |. [online] Available at: http://www.pbs.gov.au/medicine/item/10460M. [Accessed 6 Oct. 2018].

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches for posaconazole therapeutic drug monitoring and their clinical benefits;European Journal of Clinical Pharmacology;2024-09-09

2. Real-world Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels;Open Forum Infectious Diseases;2024-03-29

3. Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?;Expert Review of Clinical Pharmacology;2024-02-21

4. A review of prophylactic regimens to prevent invasive fungal infections in hematology patients undergoing chemotherapy or stem cell transplantation;Expert Review of Hematology;2023-12-02

5. Antibacterials/posaconazole;Reactions Weekly;2023-12-02